• Publications
  • Influence
Tularemia as a biological weapon: medical and public health management.
OBJECTIVE The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals if tularemia is used as a
Botulinum toxin as a biological weapon: medical and public health management.
People potentially exposed to botulinum toxin should be closely observed, and those with signs of botulism require prompt treatment with antitoxin and supportive care that may include assisted ventilation for weeks or months.
Clinical practice guidelines for antimicrobial prophylaxis in surgery.
These guidelines are intended to provide practitioners with a standardized approach to the rational, safe, and effective use of antimicrobial agents for the prevention of surgical-site infections based on currently available clinical evidence and emerging issues.
Hospital outbreak of Middle East respiratory syndrome coronavirus.
Person-to-person transmission of MERS-CoV can occur in health care settings and may be associated with considerable morbidity and surveillance and infection-control measures are critical to a global public health response.
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
Transplant-Associated Infection Surveillance Network data provide important insights into the timing and incidence of IFIs among organ transplant recipients, which can help to focus effective prevention and treatment strategies.
Clinical practice guidelines for antimicrobial prophylaxis in surgery.
These guidelines were developed jointly by the American Society of Health-System Pharmacists (ASHP), the Infectious Diseases Society of America (IDSA), the Surgical Infection Society (SIS), and the
Anthrax as a biological weapon, 2002: updated recommendations for management.
This revised consensus statement presents new information based on the analysis of the anthrax attacks of 2001, including developments in the investigation of the Anthrax Attacks of 2001; important symptoms, signs, and laboratory studies; new diagnostic clues that may help future recognition of this disease; updated antibiotic therapeutic considerations; and judgments about environmental surveillance and decontamination.
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET)
In this national prospective surveillance study of IFIs in HSCT recipients, the cumulative incidence was highest for aspergillosis, followed by candidiasis, and understanding the epidemiologic trends and burden of IFI may lead to improved management strategies and study design.
Eliminating catheter-related bloodstream infections in the intensive care unit*
Multifaceted interventions that helped to ensure adherence with evidence-based infection control guidelines nearly eliminated CR-BSIs in the authors' surgical ICU.
Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options.
  • L. Maragakis, T. Perl
  • Biology, Medicine
    Clinical infectious diseases : an official…
  • 15 April 2008
The development or discovery of new therapies, well-controlled clinical trials of existing antimicrobial regimens and combinations, and greater emphasis on the prevention of health care-associated transmission of multidrug-resistant Acinetobacter infection are essential.